Home

Report

The Use of Medicines in the U.S. 2024

The Use of Medicines in the U.S. 2024

IQVIA
Pages 78 Pages

This annual report analyzes medicine usage and spending trends in the U.S. following the COVID-19 pandemic. Prescription volume continues to grow, driven by chronic disease treatments, GLP-1 therapies, and specialty medicines. Spending has accelerated despite declining COVID-related products. The report examines patient out-of-pocket costs, biosimilar impacts, and the influence of the Inflation Reduction Act. Looking ahead to 2028, it highlights key drivers shaping affordability, access, and innovation.

Join for free to read

You Might Also Like


The Use of Medicines in the U.S.
Report The Use of Medicines in the U.S.
IQVIA

The Use of Medicines in the U.S.
Report The Use of Medicines in the U.S.
IQVIA

The Use of Medicines in the U.S. 2023
Report The Use of Medicines in the U.S. 2023
IQVIA

The Global Use of Medicines 2024 Institute Report
Infographic The Global Use of Medicines 2024 Institute Report
IQVIA

More from IQVIA


The Use of Medicines in the U.S.
Report The Use of Medicines in the U.S.
IQVIA

The Use of Medicines in the U.S.
Report The Use of Medicines in the U.S.
IQVIA

The Use of Medicines in the U.S. 2023
Report The Use of Medicines in the U.S. 2023
IQVIA

The Global Use of Medicines 2024 Institute Report
Infographic The Global Use of Medicines 2024 Institute Report
IQVIA
© 2026 Contentree.  All Rights Reserved   |   Privacy and Cookies   |   Legal   |   Do not sell my info